No Data
No Data
Tyra Biosciences (NASDAQ:TYRA) Is In A Good Position To Deliver On Growth Plans
Just because a business does not make any money, does not mean that the stock will go down. For example, although software-as-a-service business Salesforce.com lost money for years while it grew rec
Express News | Tyra Biosciences Inc. : Oppenheimer Raises Target Price to $28 From $25
Tyra Biosciences Price Target Maintained With a $28.00/Share by Wedbush
Tyra Biosciences Price Target Maintained With a $28.00/Share by Wedbush
Express News | HC Wainwright & Co. Reiterates Buy on Tyra Biosciences, Maintains $23 Price Target
Express News | Tyra Biosciences Q1 2024 Adj EPS $(0.35) Beats $(0.46) Estimate
Express News | Tyra Biosciences Inc: Current Cash, Cash Equivalents and Marketable Securities on Hand as of Q1 Allow Co to Execute on Plans Through at Least 2026